Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.

Title : Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease

Source : PubMed
ID : 28722466
Authors : Tanner, Nichole T.; Dai, Lin; Bade, Brett C.; Gebregziabher, Mulugeta; Silvestri, Gerard A
Year : 2017
Disease Category : Cancer
Focused Population : Elderly patients
Priori/Posteriori : Posteriori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : No
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : Yes
Trial participants vs. general population (from EHR, survey, a cohort, etc) : Yes
Real-world data sources : Surveillance, Epidemiology, and End Results program (SEER)-Medicare databases between 1998 and 2010
Target Population Data Type Levels : National